Scotts Miracle-Gro stock has clawed back some ground with a 13.6% gain year to date, yet shareholders are still facing a decline of about 54.4% over five years, while the current Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading at a discount to that estimate and market multiples suggest pricing that is closer to fair value.

• Over the last five years, Scotts Miracle-Gro has fallen about 54.4%, which puts a spotlight on whether the recent recovery meaningfully changes the long term picture for existing and prospective investors.
• The key support for the valuation can be the company’s ability to convert revenue into consistent cash flows, while a central risk is that any pressure on margins or balance sheet strength may limit how quickly that cash can grow.
• The broader checks show a mixed picture rather than a clear bargain or clear overvaluation, with Scotts Miracle-Gro scoring 3 out of 6 on valuation.

The issue now is whether the current discount to the intrinsic value estimate offers enough compensation for the business risks that Scotts Miracle-Gro still carries.

Is Scotts Miracle-Gro a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) model values Scotts Miracle-Gro by projecting the cash the business could return to shareholders and discounting it back to today. On this view, the company’s latest twelve month free cash flow sits at about $390 million. The model assumes cash flows that generally level off rather than climb aggressively over time.

Those cash flow estimates feed through to an intrinsic value of about $81.68 per share. Compared with the current share price, that implies the stock is trading at roughly a 17.3% discount. This suggests the market is pricing in more caution on Scotts Miracle-Gro’s future cash generation than the DCF model does.

On the model’s numbers, Scotts Miracle-Gro stock currently screens as undervalued relative to its estimated intrinsic value.

Our Discounted Cash Flow (DCF) analysis suggests Scotts Miracle-Gro is undervalued by 17.3%. Track this in your watchlist or portfolio, or discover 38 more high quality undervalued stocks.

Is Scotts Miracle-Gro Fairly Priced on Earnings?

The P/E ratio is a useful cross check for Scotts Miracle-Gro because it anchors the share price to the company’s current earnings. Scotts Miracle-Gro trades on a P/E of about 19.1x, compared with an industry average of roughly 25.2x for chemicals stocks and a peer group average near 51.4x. On simple comparisons, that puts the stock at a lower earnings multiple than both the sector and peers.

A more tailored view comes from the modelled fair P/E ratio of about 18.7x, which reflects factors such as Scotts Miracle-Gro’s risk profile, margins and scale. The current 19.1x multiple sits only slightly above this fair level, so the gap is small and does not point to a clear discount or premium once those fundamentals are taken into account.

Overall, Scotts Miracle-Gro appears to be priced broadly in line with what the P/E framework indicates as fair.

The Scotts Miracle-Gro Narrative: What Would Justify Today's Price?

Given the mixed signals from Scotts Miracle-Gro's cash flow and P/E checks, Simply Wall St Narratives act as the bridge between those numbers and the expectations that would need to play out for the stock to be worth significantly more or less than today's price. Each Narrative sets out a clear view on where Scotts Miracle-Gro's growth, margins and risks could head next so you can compare that story with future results as new information emerges on the Community page.

Scotts Miracle-Gro attracts sharply different views, with one community camp focused on margin recovery and another cautious on how much risk is already priced in.

Bull case: 16% undervalued

"Ongoing cost savings and automation in the supply chain, with over US$100 million in cost reductions already captured toward a US$180 million target, and continued investment in robotics, AI and SKU rationalization. Management directly ties these initiatives to gross margin gains, improved EBITDA and stronger free cash flow..."

Bear case: 55% overvalued

"Add exposure to the volatile cannabis cultivation market, and the stock quickly fell out of favor with the market..."

Do you think there's more to the story for Scotts Miracle-Gro? Head over to our Community to see what others are saying!

The Bottom Line

For Scotts Miracle-Gro, the Discounted Cash Flow (DCF) view suggests the stock trades at a material discount to intrinsic value, while the earnings multiple points to pricing that is roughly in line with what the business currently delivers. That split largely comes down to how much faith you put in the cash flow outlook versus the market’s read on growth, risk and comparable stocks. From here, the real swing factor is whether Scotts Miracle-Gro can sustain and protect cash generation, particularly through margins and balance sheet discipline, so that the current discount looks like an opportunity rather than a value trap.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.